Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2
- 3 January 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (1) , 39-43
- https://doi.org/10.1016/s0960-894x(99)00577-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education (BSRI-96-3448)
- Ministry of Health and Welfare (HMP-98-D-4-0027)
This publication has 12 references indexed in Scilit:
- Structure of Human Methionine Aminopeptidase-2 Complexed with FumagillinScience, 1998
- The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2Proceedings of the National Academy of Sciences, 1997
- Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicinChemistry & Biology, 1997
- Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes.Proceedings of the National Academy of Sciences, 1995
- Prediction of the Coding Sequences of Unidentified Human Genes. III. The Coding Sequences of 40 New Genes (KIAA0081-KIAA0120) Deduced by Analysis of cDNA Clones from Human Cell Line KG-1DNA Research, 1995
- Structure of the cobalt-dependent methionine aminopeptidase from Escherichia coli: a new type of proteolytic enzymeBiochemistry, 1993
- Angiogenesis.Journal of Biological Chemistry, 1992
- Chemical Modification of Fumagillin. I. 6-O-Acyl, 6-O-Sulfonyl, 6-O-Alkyl, and 6-O-(N-Substituted-carbamoyl)fumagillols.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Tumor AngiogenesisPublished by Elsevier ,1985